Hopt U T, Sullivan W, Hoffman R, Simmons R L
Transplantation. 1980 Dec;30(6):411-6. doi: 10.1097/00007890-198012000-00005.
The migration of indium-III-labeled specifically sensitized lymphocytes (SSLs) and unsensitized spleen lymphocytes (ULs) into sponge matrix allografts was studied in irradiated mice. Intravenously injected SSLs were preferentially recruited to the graft bearing the sensitizing alloantigen. High numbers of these SSLs, however, were attracted regardless of their immunological specificity to a third-party graft, when cells sensitized against the third-party antigen were given simultaneously. When SSLs were injected locally into a specific and third-party graft, i.v. injected ULs also homed preferentially to the specific graft. Prior treatment of SSLs with anti-theta serum and complement abrogated their cell recruiting capacity. The percentage of injected lymphocytes recruited to the specific allograft during the first 36 hr increased with the number of SSLs injected. The duration of augmented lymphocyte recruitment, however, was inversely related to the number of SSLs injected into the graft. Furthermore, there is some evidence that SSLs which have been recruited to an allograft migrate to a second site of antigen challenge and initiate there a high lymphocyte recruitment. These results suggest that increased lymphocyte recruitment to an allograft is initiated by an immunologically specific interaction between SSLs and alloantigen. The cells, however, which are preferentially recruited to an allograft, comprise small unsensitized lymphocytes and SSLs regardless of their immunological specificity. Lymphocytes with cell recruiting activity are T cells and appear to be very mobile in vivo. The mechanism described might have an important amplifying effect on allograft rejection.
在受辐照小鼠中研究了铟 - III标记的特异性致敏淋巴细胞(SSLs)和未致敏脾淋巴细胞(ULs)向海绵基质同种异体移植物中的迁移。静脉注射的SSLs优先募集到携带致敏同种异体抗原的移植物中。然而,当同时给予针对第三方抗原致敏的细胞时,大量这些SSLs无论其免疫特异性如何都会被吸引到第三方移植物中。当将SSLs局部注射到特异性和第三方移植物中时,静脉注射的ULs也优先归巢到特异性移植物中。用抗θ血清和补体预先处理SSLs可消除其细胞募集能力。在最初36小时内募集到特异性同种异体移植物中的注射淋巴细胞百分比随注射的SSLs数量增加而增加。然而,淋巴细胞募集增强的持续时间与注射到移植物中的SSLs数量呈负相关。此外,有一些证据表明,已募集到同种异体移植物中的SSLs迁移到第二个抗原攻击部位并在那里引发高淋巴细胞募集。这些结果表明,同种异体移植物中淋巴细胞募集增加是由SSLs与同种异体抗原之间的免疫特异性相互作用引发的。然而,优先募集到同种异体移植物中的细胞包括小的未致敏淋巴细胞和SSLs,无论其免疫特异性如何。具有细胞募集活性的淋巴细胞是T细胞,并且在体内似乎非常具有流动性。所描述的机制可能对同种异体移植排斥反应具有重要的放大作用。